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A Recombinant Secondary 
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Sebyung Kang1
We construct a novel recombinant secondary antibody mimic, GST-ABD, which can bind to the Fc 
regions of target-bound primary antibodies and acquire multiple HRPs simultaneously. We produce it 
in tenth of mg quantities with a bacterial overexpression system and simple purification procedures, 
significantly reducing the manufacturing cost and time without the use of animals. GST-ABD is 
effectively conjugated with 3 HRPs per molecule on an average and selectively bind to the Fc region of 
primary antibodies derived from three different species (mouse, rabbit, and rat). HRP-conjugated GST-
ABD (HRP-GST-ABD) is successfully used as an alternative to secondary antibodies to amplify target-
specific signals in both ELISA and immunohistochemistry regardless of the target molecules and origin 
of primary antibodies used. GST-ABD also successfully serves as an anchoring adaptor on the surface of 
GSH-coated plates for immobilizing antigen-capturing antibodies in an orientation-controlled manner 
for sandwich-type indirect ELISA through simple molecular recognition without any complicated 
chemical modification.
Binding specificity and high affinity to any given target molecule are essential features for in vitro and/or 
in vivo diagnostics and for many other biotechnological and biomedical applications. Antibodies have been 
widely used as ligands for the specific detection of biomarkers in vitro and/or in vivo, the enrichment of low 
abundant molecules in complex samples, and the targeted delivery of therapeutics and/or diagnostics because 
they have an extremely high binding affinity and specificity to their target molecules and because a variety of 
antibodies to virtually any desired target can be readily obtained on demand1–4. An immunoassay is a biochemical 
method that uses antibodies to detect the presence of specific biomolecules of interest and to measure their con-
centrations in a complex biological sample. Most immunoassays, including enzyme-linked immunosorbent assay 
(ELISA) and immunohistochemistry, commonly use two different types of antibodies or immunoglobulins (Igs), 
those are, primary and secondary antibodies. Each primary antibody binds to its own specific target molecules 
with extremely high affinity and selectivity, thus ensuring the accuracy and precision of the assay. Therefore, the 
appropriate primary antibodies should be chosen to guarantee the successful detection and accurate quantifica-
tion of target molecules in immunoassays. On the other hand, the secondary antibodies recognize and bind to the 
target-bound primary antibodies regardless of the target molecules. The secondary antibodies are generally con-
jugated with enzymes, such as horseradish peroxidases (HRP), which repeatedly convert undetectable substrates 
to detectable products, resulting in significant signal amplification for the detection of low abundance target 
molecules. Although secondary antibodies are widely used for antibody-mediated target detection and signal 
amplification, the mass production of secondary antibodies requires expensive animal use as well as high man-
ufacturing costs and time compared to those of recombinant protein production with bacterial overexpression 
systems. However, it is possible to replace enzyme-conjugated secondary antibodies if there are simple secondary 
antibody mimics that can specifically bind to the Fc region of the primary antibodies and provide sites for the 
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conjugation of signal-amplifying enzymes simultaneously. Moreover, universal secondary antibody mimics that 
can broadly bind to the Fc region of the primary antibodies derived from multiple species such as mouse, rabbit, 
and rat are particularly useful because they would eliminate the need to prepare individual primary-secondary 
antibody pairs. Protein A full length protein and extracellular domain of Fcγ receptors have been used as tem-
plates for developing recombinant secondary antibody mimics, because they have an antibody-binding capability.
Sandwich-type indirect ELISA system is the most popular and convenient ELISA format, which is gener-
ally comprised of four major components: antigen-capturing antibodies, which are anchored on the surface of 
plates; target antigens; antigen-detecting primary antibodies; and signal-amplifying secondary antibodies. One 
of the most challenging tasks in this format is effectively immobilizing the antigen-capturing antibodies on the 
surface of the ELISA plates without significantly altering the capturing capability of the immobilized antibodies. 
Currently, the most widely used antibody immobilization methods are chemical modifications and the physical 
adsorption of antigen-capturing antibodies5,6. However, chemical immobilizations often cause significant inac-
tivation or denaturation of the antigen-capturing antibodies, impairing their binding capability, and physically 
adsorbed antigen-capturing antibodies are frequently detached from the plates during the multiple washing and 
sample application steps of ELISA, mainly owing to the weak binding of the antibodies to the plates5,6. In addition, 
both chemical modification and physical adsorption of antigen-capturing antibodies often result in the immo-
bilization of the antigen-capturing antibodies in the wrong orientation, causing an alteration of the capturing 
efficiency of the immobilized antibodies. Therefore, there are demands for the development of more effective and 
simple methods and materials for the immobilization of antigen-capturing antibodies to plates, without altering 
their antigen-binding capability.
In this study, we constructed a novel recombinant secondary antibody mimic (GST-ABD) by genetically 
combining the antibody-binding domain (ABD)7–9 with glutathione-S-transferase (GST) using a flexible linker. 
GST-ABD was produced in large quantities (>10 mg/L culture) using a bacterial overexpression system and 
applied to various immunoassay systems, including ELISA and immunohistochemistry, as an alternative to sec-
ondary antibodies and/or an anchoring adaptor for immobilizing antigen-capturing antibodies in sandwich-type 
indirect ELISA (Fig. 1). Our recombinant secondary antibody mimic, GST-ABD, can be massively produced by 
bacterial overexpression systems and simple purification procedures, significantly reducing the manufacturing 
cost and time. We successfully demonstrated that the prepared GST-ABD effectively conjugates with HRPs and 
selectively binds to the Fc region of primary antibodies to amplify target-specific signals in both ELISA and 
immunohistochemistry. We also showed that GST-ABDs effectively bind to GSH-coated plates and anchor the 
antigen-capturing antibodies on the surface of the plates in an orientation-controlled manner through simple 
molecular recognition without any complicated chemical modification.
Results and Discussion
GST and ABD are genetically fused via extra linker residues. To construct a recombi-
nant secondary antibody mimic, we prepared antibody-binding domain (ABD) isolated from protein 
A and genetically fused to the C-terminus of glutathione-S-transferase (GST) with extra linker residues 
(KDPNSGGGLVPRGSGGGCGGGTGGGSGGG) which offer an independency of each domain and provide an 
enough space for antibody access and other conjugating proteins (GST-ABD, Fig. 1). ABD of protein A, named 
as Z domain, has been known to specifically bind to the Fc region of immunoglobulin G (IgG) in an orienta-
tion-controlled manner without interfering antibodies’ binding capability7,8. GST is one of the most commonly 
used fusion tag protein that usually increases the solubility and stability of fused domains or proteins and exhibits 
specific interaction with glutathione (GSH) as well as provides addressable sites for additional chemical modifica-
tions, such as attachments of small chemicals and enzymes. Large amounts of GST-ABD (>10 mg/L culture) were 
produced in a bacterial overexpression system and were purified using simple one-step Ni-NTA agarose column 
chromatography, thus reducing the manufacturing cost and time significantly. High purity of GST-ABD (> 99%; 
Figure S1A) and the successful fusion of GST and ABD with the added linker residues (Figure S1B, calc. 35890.8 
Figure 1. Schematic representation of the preparation of a recombinant secondary mimic, GST-ABD, and 
its applications to ELISA and immunohistochemistry as an alternative to secondary antibodies. 
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Da; obs. 35890.0 Da) were confirmed with SDS-PAGE and electrospray ionization time-of-flight mass spectrom-
etry (ESI-TOF MS), respectively. Purified GST-ABD remained intact for at least a month at 4 °C.
GST-ABD serves as a universal IgG binding molecule, which captures free IgGs on a solid sur-
face as well as binds to the immobilized IgGs by simple molecular recognition. To investigate 
the binding capability of GST-ABD to antibodies derived from three different species (mouse, rabbit, and rat), we 
first monitored interactions between the immobilized GST-ABD and free IgGs in real-time using a quartz crys-
tal microbalance (QCM; Fig. 2A–C)10,11. The resonance frequencies of a GST-ABD-monolayered QCM sensor 
drastically decreased (black lines) upon the addition of all three different types of IgGs separately, whereas those 
of a GST-monolayered sample (red lines) remained unchanged (Fig. 2A–C). To determine precise associating 
and dissociating properties of GST-ABD with various types of IgGs, we carried out surface plasmon resonance 
(SPR) analyses (Fig. 2D–F)10,12. In contrast to the procedure for the QCM studies, we first immobilized each 
IgG molecule (from mouse, rabbit, or rat) on the surfaces of standard SPR CM5 chips and then introduced 
GST-ABD at several different concentrations. Rapid increases and very slow decreases in the SPR response unit 
(RU) were observed when the solutions of GST-ABD at various concentrations and the washing buffers, respec-
tively, were introduced (Fig. 2D–F), whereas no apparent change was observed upon introduction of GST protein 
and buffer (Figure S2). GST-ABD exhibited strong binding to all types of IgGs derived from three different species 
(Table 1). However, it bound most tightly to rabbit IgG (Kd, 1.31 ± 0.2 nM) and least tightly to mouse IgG (Kd, 
16.8 ± 2.2 nM). The relatively fast dissociation rate constant of mouse IgGs might cause the differences in disso-
ciation constants (Table 1). The QCM and SPR studies with various IgGs demonstrated that GST-ABD can serve 
as a universal IgG binding molecule, which binds to the immobilized IgGs as well as captures free IgGs on a solid 
surface by simple molecular recognition.
HRP-GST-ABD is used as an effective signal-amplifying secondary antibody mimic in simple 
indirect ELISA. Horseradish peroxidase (HRP) is commonly conjugated to secondary antibodies and ampli-
fies the weak signal of a target molecule in ELISA or cell and tissue imagings13–16. Since GST-ABD has four 
innate cysteines in the GST portion and an additional cysteine within the linker, we attempted to conjugate the 
EZ-Link maleimide activated horseradish peroxidase (Mal-HRP) to GST-ABD via thiol-maleimide Michael-type 
Figure 2. GST-ABD binds to immobilized IgGs as well as captures free IgGs derived from three different 
species. (A–C) QCM resonance frequency change (ΔF) profiles of either GST-ABD (black lines) or GST (red 
lines) on the gold QCM sensors and subsequent deposition of mouse (A), rabbit (B), and rat (C) IgGs on the 
monolayers of either GST-ABD (black lines) or GST (red lines). (D–F) SPR sensorgrams of GST-ABD binding 
to IgG-immobilized gold SPR sensors (black lines) and the fitting curves (red lines) for the mouse (D), rabbit 
(E), and rat (F) IgGs.
IgGs ka(M−1s−1) kd(s−1) Ka(M−1) Kd(M) Chi2
Mouse IgG 63.8 × 103 1.07 × 10−3 0.59 × 108 16.8 × 10−9 1.63
Rabbit IgG 66.6 × 103 0.09 × 10−3 0.76 × 109 1.31 × 10−9 1.32
Rat IgG 51.8 × 103 0.22 × 10−3 0.23 × 109 4.34 × 10−9 1.64
Table 1.  Binding parameters for the interactions of GST-ABD and various types of IgGs derived from 
mouse, rabbit, and rat determined by SPR analyses. (ka; associating rate constant, kd; dissociating rate 
constant, Ka; associating constant, Kd; dissociating constant).
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addition. Consequently, we obtained HRP-conjugated GST-ABD (HRP-GST-ABD) reproducibly with three HRPs 
per GST-ABD molecule on average probably due to spatial constraint of conjugating sites (Figure S3). To eval-
uate the performance of HRP-GST-ABD as an alternative to the commonly used HRP-conjugated secondary 
antibodies, we first conducted a simple indirect ELISA (Fig. 3A). We immobilized a fixed amount of BSA as a 
model antigen on the surface of the ELISA plate via physical adsorption and applied various concentrations of 
rabbit anti-BSA primary antibodies. We then loaded either HRP-conjugated anti-rabbit secondary antibodies 
or HRP-GST-ABD after extensive washings. Subsequently, we added the o-phenylenediamine (OPD) substrate 
solution and measured the absorption at 450 nm immediately or 5 min later. The absorption values increased 
linearly in both HRP-GST-ABD and anti-rabbit HRP-labeled secondary antibody–treated samples in the range of 
approximately 40 pM to 5 nM, as the concentrations of primary antibody (anti-BSA IgG) increased (Fig. 3B and 
inset). Interestingly, HRP-GST-ABD-treated samples exhibited significantly enhanced signals compared to those 
seen with anti-rabbit HRP-labeled secondary antibody (Fig. 3B) at medium and high concentrations. This is pos-
sibly due to larger numbers of conjugated HRPs in the case of HRP-GST-ABD (3 HRPs per GST-ABD molecule 
on average, Figure S3). Although we observed significant signal enhancement at medium and high concentra-
tions of primary antibodies, we did not see significant improvement in the limit of detection (LOD; Figure S4A, 
HRP-GST-ABD; 22 pM and anti-rabbit HRP-labeled secondary antibody; 25 pM). Slightly weak binding affinity 
of GST-ABD to the primary antibodies (Kd, 1.31 nM) compared to that for primary/secondary antibody pairs (Kd, 
hundredth of pM or lower) may limit their LOD.
Because GST-ABD can bind to not only rabbit IgG but also mouse IgG without any modification (Fig. 2), 
we tested whether HRP-GST-ABD can be used as a universal secondary antibody mimic against various types 
of IgGs derived from different species. We substituted rabbit primary anti-BSA IgG with mouse primary 
anti-BSA IgG and performed the same experiment as described above. While anti-rabbit HRP-labeled secondary 
antibody-treated samples did not show any signal, regardless of applied concentrations, HRP-GST-ABD-treated 
samples exhibited a graph almost identical to that of rabbit primary anti-BSA IgG (Fig. 3C). However, due to 
the weak binding affinity of HRP-GST-ABD to mouse primary antibodies, it took 5 min to obtain a similar LOD 
(29 pM) and signal response traces (Fig. 3C and S5). In addition, we performed similar experiments with the other 
antigenic protein, epithelial cell adhesion molecule (EpCAM), which is known as a biomarker for circulating 
tumor cells (CTCs)17,18. We obtained an almost identical LOD (25 pM) and linear ranges (40 pM–2.5 nM) as com-
pared to those of BSA (Fig. 3D and S4B), when we applied rabbit primary anti-EpCAM IgG and HRP-GST-ABD. 
Mouse primary anti-EpCAM also exhibited almost identical results to those of BSA (Fig. 3E and S5). Together, 
these data suggest that HRP-GST-ABD can be applied as a signal-amplifying secondary antibody mimic for any 
type of antigenic molecules once corresponding primary antibodies are available, regardless of species origin 
(rabbit, mouse, and rat).
GST-ABD serves as an anchoring adaptor for immobilizing antigen-capturing antibodies in 
sandwich-type indirect ELISA. Sandwich-type indirect ELISA system is one of the most used formats. In 
order to capture target antigenic molecules in a complex biological sample, antigen-capturing antibodies should 
be securely immobilized in the proper orientation on the surface of the ELISA plates. Chemical immobilizations 
or related methods of immobilizing antigen-capturing antibodies often impair the antigen-binding capability 
Figure 3. HRP-GST-ABD mimics signal-amplifying secondary antibodies in indirect ELISA. (A) Scheme 
showing different combinations of primary antibodies with either HRP-conjugated secondary antibodies or 
HRP-GST-ABD. (B–E) BSA (B,C) or EpCAM (D,E) are immobilized on the surface of the ELISA plates and 
various concentrations of either rabbit anti-BSA (B) or mouse anti-BSA primary antibodies (C) or either 
rabbit anti-EpCAM (D) or mouse anti-EpCAM primary antibodies (E) are applied. Linear responses of each 
measurement are plotted as insets of each graph.
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of capturing antibodies due to alterations in their antigen-binding sites, denaturation, or random orientation of 
the antibodies5,6. Since GST-ABD has species-independent antibody-binding capability at one end (ABD) and 
glutathione (GSH)-binding capability at the other end (GST), the GST portion of GST-ABD will bind to the 
surface of the GSH-coated plates and the remaining ABD portion can bind to the Fc regions of the capturing anti-
bodies with the proper orientation to detect their target antigens (Fig. 4A). We obtained commercially available 
GSH-coated plates and treated them with various concentrations of GST-ABDs. We observed the global curve, 
which increased as the concentration of GST-ABD increased and was finally saturated, whereas the controls 
(mono-streptavidin-fused ABD) did not (Figure S6). Subsequently, we determined the optimal amounts of rea-
gents at each step in the sandwich-type indirect ELISA prior to applying this system to detecting antigens (Figures 
S7 and S8). We immobilized fixed amounts of GST-ABD on the surface of the GSH-coated plates, saturated 
them with capturing antibodies for either anti-BSA or anti-EpCAM rabbit IgGs individually, and added different 
amounts of BSA or EpCAM and removed unbound BSA or EpCAM with extensive washing; subsequently, we 
determined the amounts of antigens as done typically for a sandwich-type indirect ELISA (Fig. 4B,C). LODs 
(Figure S4C; BSA: 33 pM and EpCAM: 36 pM) comparable to and linear responses (range of 35 pM to 80 nM) 
almost identical to those of previous simple indirect ELISAs were obtained (Fig. 4). All the immobilization pro-
cesses for antibodies and antigens used in this approach were achieved simply by biomolecular recognition (GST 
to GSH and ABD to Fc of IgGs) in an orientation-controlled manner without any additional chemical modifica-
tions. The density of antigen-capturing antibodies can be easily controlled by the amounts of anchored GST-ABD 
we introduced, because GST/GSH and ABD/IgG interactions are strong and specific enough. We believe our 
approach could minimize deviations resulted from chemical immobilizations of antigen-capturing antibodies, 
such as antibody inactivation or random orientation.
HRP-GST-ABDs are as effective as HRP-conjugated secondary antibodies in cell and tissue 
TSA assays. The tyramide signal amplification (TSA) assay is frequently used to detect low-abundance bio-
molecules such as proteins, DNA, and RNA in cells and tissues13,16. We next examined if HRP-GST-ABD can 
serve as a substitute for HRP-conjugated secondary antibodies in immunohistochemistry. We first performed 
TSA-based immunohistochemistry for two cancer cell lines, SKBR3 and KB, that overexpress HER2 and integrin 
α β γ 3 receptors, respectively, on the cell surface, by using the corresponding primary IgGs (anti-HER2 rabbit and 
anti-integrin α β γ 3 mouse IgGs, respectively). We first treated SKBR3 cells with anti-HER2 rabbit primary IgGs 
or KB cells with anti-integrin α β γ 3 mouse IgGs and subsequently incubated them with either HRP-conjugated 
anti-rabbit secondary antibody or HRP-GST-ABD (Fig. 5). We observed slightly weak signal enhancements in 
HRP-GST-ABD treated SKBR3 and KB cells in comparison to those of HRP-conjugated anti-rabbit secondary 
antibody-treated SKBR3 (Fig. 5A–C) probably due to slightly weak binding affinity of GST-ABD to the pri-
mary antibodies compared to that for primary/secondary antibody pairs as we discussed in the ELISA section. 
Nevertheless, HRP-GST-ABD selectively bound to the surface target-bound primary antibodies and sufficiently 
enhanced fluorescence signal under the typical TSA condition (Fig. 5, 1AB 1x) regardless of the species origin 
of primary antibodies. However, we did not detect any apparent signal enhancement in KB cells treated with 
anti-integrin α β γ 3 mouse IgGs and subsequently incubated with HRP-conjugated anti-rabbit secondary anti-
body (Fig. 5D) due to species mismatch between primary and secondary antibodies (mouse vs. rabbit). When we 
applied HRP-conjugated anti-mouse secondary antibody instead of anti-rabbit with anti-integrin α β γ 3 mouse 
IgGs, we observed almost identical signal enhancements in both HRP-GST-ABD and HRP-conjugated secondary 
antibody-treated KB cells in all measured ranges (Figure S9). These results suggest again that HRP-GST-ABD can 
be utilized as a universal signal-amplifying secondary antibody mimic for target-cell detection once correspond-
ing primary antibodies are available, regardless of species origin (rabbit, mouse, and rat).
TSA-based immunohistochemistry for sectioned tissues and whole mount samples is more challenging 
than that of cultured cells owing to the heterogeneity and complexity of the samples as well as the require-
ment for higher specificity and signal-to-noise ratio19,20. To this end, we prepared Xenopus embryos and per-
formed TSA-based immunostaining with HRP-GST-ABD. Stage 43 Xenopus embryos develop major organs 
and tissues and are suitable for staining of specific tissues in sectioned or whole mount samples19–21. We tested 
Figure 4. GST-ABD serves as an anchoring adaptor on the surface of GSH-coated plates for immobilizing 
antigen-capturing anti-bodies in an orientation-controlled manner in sandwich-type indirect ELISA. (A) 
Scheme showing the adaptation of GST-ABD as an anchoring adaptor for antigen-capturing antibodies. (B,C) 
GST-ABDs are spread on the surface of GSH-coated plates and saturated with capturing antibodies, either anti-
BSA rabbit IgGs (B) or anti-EpCAM rabbit IgGs (C). Various amounts of BSA (B) or EpCAM (C) are added. 
Linear responses for each measurement are plotted as insets of each graph.
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several tissue-specific antibodies, such as an anti-acetylated tubulin antibody (Fig. 6A,E and Figure S10A) and 
anti-myosin heavy chain (MHC) antibody (Figure S11C) to visualize the nerve fibers and muscles, respectively. 
We also tested anti-phospho-histone H3 (Fig. 6B,D, Figures S10C and S12A) and anti-fibronectin antibodies 
(Fig. 6C and Figure S11A) to detect subcellular localization of the targets in sectioned and whole mount samples. 
In all cases, HRP-GST-ABD resulted in high target-specific signal amplification for both sectioned (Fig. 6A–C 
and S11C) and whole mount samples (Fig. 6D,E) that were comparable to those of HRP-conjugated second-
ary antibodies (Figures S10–12) regardless of the origin of the primary antibodies (rabbit or mouse) used. 
Although HRP-GST-ABD exhibited slightly weaker affinity to primary antibodies in comparison to general 
HRP-conjugated secondary antibodies, small-sized HRP-GST-ABD may efficiently penetrate the sectioned sam-
ples and selectively bind to the target-bound primary antibodies resulting in high target-specific signal amplifi-
cation. Alternatively, we could substantially reduce the sample preparation time by association with the primary 
antibody and HRP-GST-ABD together prior to sample treatment, in contrast to the classic sequential treatment 
with a primary antibody followed by that with a secondary antibody, which is necessary to avoid antibody aggre-
gation caused by the multivalent antigen-binding sites of secondary antibodies.
Antibodies are frequently used to detect specific target molecules such as proteins and chemically labeled 
probes in mixed biological samples. In most cases of immuno-detection protocols, enzyme-conjugated secondary 
antibodies amplify signals. Although the secondary antibodies possesses very high specificity and binding affinity 
to primary antibodies, several limitations still need to be improved.
In this research, we have developed a novel recombinant secondary antibody mimic, GST-ABD, and produced 
tenth of mg quantities inexpensively using bacterial overexpression systems with a one-step purification method 
(Fig. 7). GST-ABD was effectively conjugated with 3 HRPs per molecule on an average and selectively bound 
to the Fc region of primary antibodies derived from three different species (mouse, rabbit, and rat) to amplify 
target-specific signals in both ELISA and immunohistochemistry (Fig. 7). GST-ABD also successfully served as 
an anchoring adaptor on the surface of GSH-coated plates for immobilizing antigen-capturing antibodies in an 
orientation-controlled manner for sandwich-type indirect ELISA. This was achieved through simple molecular 
interaction without any complicated chemical modifications (Fig. 7).
In additions to its versatility, GST-ABD possesses other beneficial reasons to replace secondary antibodies. 
All secondary antibodies are produced in higher vertebrate animals such as goat, sheep and donkey. In contrast, 
GST-ABD is produced in E. coli with much simpler procedures thereby it would minimize the use of animals 
and significantly reduce the batch to batch variations in its binding affinity and specificity (Fig. 7). Our approach 
described here may provide new opportunities to develop a simple and inexpensive immunoassay platform.
Materials and Methods
Construction, expression, and purification of a recombinant secondary antibody mimic (GST-
ABD). The optimized gene that encodes antibody-binding domain (ABD, 58 amino acids) with 27 extra amino 
acids at the N-terminus was synthesized and genetically added to the C-terminal end of glutathione-S-transferase 
(GST) containing a hexahistidine tag at the N-terminal end within the IPTG-inducible pETDuet expression 
Figure 5. Tyramide signal amplification (TSA) assays with HRP-GST-ABD or HRP-conjugated secondary 
antibodies in the presence of primary antibodies derived from rabbits. SKBR3 and KB cells overexpress 
HER2 and integrin α β γ 3 receptors, respectively, on their surfaces. SKBR3 (A,B) and KB (C,D) cells were treated 
with anti-HER2 rabbit (A,B) and anti-integrin α β γ 3 mouse (C,D) primary IgGs, respectively, and subsequently 
incubated with HRP-conjugated anti-rabbit secondary antibodies (A,D) or HRP-GST-ABD (B,C) in the 
presence of TSA reagents. Treatment amounts for primary anti-HER2 rabbit and anti-integrin α β γ 3 mouse 
antibodies are indicated at the top of each column. 1AB 1x represents the typical amount of primary antibodies 
used for TSA assays.
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vector (Invitrogen). The amplified DNAs were transformed into the competent E. coli strain BL21 (DE), and the 
recombinant secondary antibody mimic (GST-ABD) was overexpressed overnight at 30 °C. The cells were har-
vested by high-speed centrifugation, treated with lysozyme (50 μg/ml) at room temperature for 1 hr, sonicated for 
10 min in 30-sec intervals, and subsequently centrifuged at 12,000 g for 1 hr to obtain the supernatant containing 
GST-ABD. The resultant GST-ABD was further purified by immobilized metal affinity chromatography (IMAC). 
The purity and molecular mass of GST-ABD were investigated with SDS-PAGE, UV/visible spectroscopy, and 
mass spectrometry.
Quartz crystal microbalance (QCM) measurements. Standard gold QCM sensors and Q-Sense E4 
(Biolin Scientific) were used as previously described, with slight modifications10,11. The overall system was oper-
ated in the flow mode with a pump maintaining temperature at 25.0 ± 0.1 °C. Each sample solution was intro-
duced into the measurement chamber with a pump, and phosphate buffer (50 mM phosphate, 100 mM NaCl, 
pH 6.5) was used for washing prior to each sample application. Then, 0.1 mg/ml of GST-ABD and GST or rabbit, 
mouse, or rat IgGs was introduced in the same phosphate buffer. Resonance frequencies at seven harmonics (5, 
15, 25, 35, 45, 55, and 65 MHz) were measured simultaneously and, for clarity, only the normalized frequencies of 
the third overtone have been presented10,11.
Surface plasmon resonance (SPR) analyses. SPR experiments were conducted with carboxyl dextran 
CM5 standard gold sensor chips on a Biacore 3000 device at 25 °C using both a HBS-EP buffer as an immobi-
lization solution and a PBS buffer as a running solution10. Rabbit, mouse, and rat IgGs were initially coupled 
Figure 6. HRP-GST-ABD can effectively and efficiently amplify the signal in TSA-based immunostaining. 
(A) Anti-acetylated tubulin primary antibodies (mouse) are used to detect nerve fibers in sectioned Xenopus 
samples. The forebrain region is sectioned transversely and the nerve fibers are visualized with HRP-GST-ABD 
and tyramide-Alexa 488 (green). The nuclei are stained with DAPI in blue. The nerve fibers in the forebrain 
are clearly stained in green (A’) and the ciliary axonemes are specifically stained only in multiciliated cells (A”). 
The scale bars in a’ and a” are 20 μm and 5 μm, respectively. (B) Anti-phospo-histone H3 primary antibodies 
(rabbit) are used to detect proliferating cells in green. The tubulins are stained in red with anti-tubulin 
antibodies (rabbit) and the Alexa-555 conjugated anti-rabbit secondary antibodies as a counterstain after the 
TSA reaction. Note that the Alexa-555 conjugated anti-rabbit secondary antibodies also detected the anti-
phospho-histone H3 primary anti-bodies, which are used for the TSA reaction, and the green signals amplified 
by HRP-GST-ABD precisely overlapped with the red signals only in the nuclei (B’,B”). The scale bars in B’ and 
B” are 20 μm and 5 μm, respectively. (C) An anti-fibronectin primary antibody (mouse) was used to detect the 
extracellular matrix. The scale bars in (C’ ,C” ) are 20 μm and 5 μm, respectively. (D,E) The anti-phospho-histone 
H3 primary antibody (rabbit, D) or anti-acetylated tubulin primary antibody (mouse, e) are used again to 
stain whole mount embryos. An anti-actin antibody is used to visualize the cell boundaries in red (D). (D’ ,D” ) 
show the confocal images in indicated sectioning planes. (E) HRP-GST-ABD successfully penetrates through 
whole mount embryo body and specifically amplified the signals of target molecules in whole mount samples. 
Acetylated-tubulin antibodies also detected multiciliated cells in the epidermis in addition to the nerve fibers. 
The scale bars in d and e are 20 μm. All control images obtained by using the regular HRP-conjugated secondary 
antibodies (rabbit and mouse) are presented in the supporting Figures (S10–12).
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to the carboxyl functional groups exposed on the surface of a CM5 sensor chip via standard amine-coupling 
chemistry. In brief, a mixture of EDC (0.5 mg/ml) and NHS (0.5 mg/ml) was gently mixed and injected onto the 
sensor chip at a flow rate of 10 μl/min to activate carboxyl groups of the sensor chips. Subsequently, 0.1 mg/ml 
of rabbit, mouse, and rat IgGs was individually injected into three different channels at the same flow rate for 
7 min to immobilize them on the surfaces of the sensor chips. Unused excess reactive groups of CM5 sensor chips 
were blocked with 1 M ethanolamine (pH 8.0). Various amounts of GST-ABD or GST (54, 108, 216, and 432 nM) 
were loaded onto the IgG-immobilized CM5 sensor chips at a flow rate of 10 μl/min for 7 min. The binding and 
releasing kinetics of GST-ABD to various IgGs were analyzed by Biaevaluation software using the 1:1 Langmuir 
binding model6.
Chemical conjugations of fluorescent dyes or HRP to GST-ABD. To conjugate the thiol-reactive 
fluorescent dye fluorescein-5-maleimide (F5M) to GST-ABD, GST-ABD was incubated with 10 mol equivalents 
of F5M at room temperature with vigorous shaking overnight22. Unreacted free F5M was removed by extensive 
dialysis against phosphate buffer (50 mM phosphate, 100 mM NaCl, pH 6.5) overnight. The degree of F5M conju-
gation to GST-ABD was evaluated with both ESI-TOF mass spectrometer and UV/Vis spectrophotometer. On an 
average, three fluoresceins were attached to each GST-ABD. HRP-conjugated GST-ABD (HRP-GST-ABD) was 
produced by conjugating EZ-Link Maleimide Activated Horseradish Peroxidase (Mal-HRP, Thermo Scientific) 
to GST-ABD. GST-ABD was incubated with either 2.5, 5, or 10 mol equivalents of Mal-HRP at room tempera-
ture with vigorous shaking overnight. Unconjugated free Mal-HRPs and GST-ABDs were removed by using a 
Centricon ultrafiltration unit (Millipore, MWCO: 100,000 Da). Treatment of GST-ABD with 10 mol equivalents 
of Mal-HRP resulted in complete consumption of GST-ABD to produce HRP-GST-ABD reproducibly, leaving 
some extra free Mal-HRPs, which were easily removed with a Centricon ultrafiltration unit.
Simple indirect ELISA. Model antigens, BSA and EpCAM (Santa Cruz and Sino Biological Inc., respec-
tively) were dissolved in PBS to prepare the appropriate protein solution (final concentration, 2 nM). Then, 
each protein solution (100 μL each) was loaded in the wells of an Immuno MicroWell 96-well plate (Maxisorp, 
flat-bottom, pinchibar, 400 μL) and incubated at 4 °C overnight to immobilize the target proteins on the surface of 
the plate through physical adsorption. The next day, each well was washed three times with 250 μL of PBS buffer 
with 0.1% Tween 20 (PBST). The blocking buffer (PBS, 0.5% Tween 20, 5% goat serum) was loaded (200 μL each) 
and incubated at 37 °C for 1 hr. After blocking, the solutions of primary antibodies against BSA (rabbit antibodies 
purchased from Santa Cruz Biotech and mouse antibodies from Abcam) or EpCAM (rabbit and mouse antibod-
ies purchased from Sino Biological Inc.) were prepared with the PBS buffer by using serial dilutions. The solutions 
(100 μL each) were loaded in the wells of the BSA or EpCAM-immobilized plates and incubated at 37 °C for 1 hr. 
Each well was washed three times with 250 μL of PBST. Subsequently, 50 nM of HRP-conjugated anti-rabbit or 
anti-mouse secondary antibodies or HRP-GST-ABD were added (100 μL each) to the prepared sample wells and 
mixtures were incubated at 37 °C for 1 hr and then washed three times with 250 μL of PBST. The substrate solu-
tion of HRP was prepared using the SIGMAFAST OPD kit (Sigma-Aldrich) as per manufacturer instructions 
(0.4 mg/mL o-phenylenediamine [OPD], 0.4 mg/mL urea hydrogen peroxide, 0.05 M phosphate-citrate, pH 5.0) 
and 100 μL of the solution was loaded into each well. Reaction mixtures were incubated at room temperature for 
1 or 5 min depending on the sample sets and 100 μL of 2 N H2SO4 solution was added immediately into each well 
to stop the reaction. The absorbance at 450 nm of each well was monitored by a multimode microplate reader, 
Infinite® 200 PRO (TECAN). All the experiments were conducted three times independently and plotted with 
errors.
Sandwich-type indirect ELISA. GST-ABD was prepared in PBS to obtain a final concentration of 4 nM. 
The prepared solutions of GST-ABD (100 μL each) were loaded into the wells of a glutathione (GSH)-coated plate 
Figure 7. Schematic diagram comparing secondary antibodies and GST-ABD. GST-ABD can be produced 
with much simpler procedures without the use of animals and possesses several advantages, such as species-
independency and monovalency, compared to the conventional secondary antibodies.
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(clear, 8-well strips, Thermo Scientific Pierce) and incubated at 37 °C for 2 hr to allow GST-ABD to bind to immo-
bilized GSH on the surface of plates. Each well was washed three times with 250 μL of PBST to remove excess 
GST-ABD. The solutions of capturing primary antibodies against BSA (rabbit IgG) and EpCAM (rabbit IgG) were 
prepared and added (100 μL each) to the GST-ABD-anchored wells. After the 2-hr incubation at 4 °C, each well 
was washed three times with 250 μL of PBST. The BSA and EpCAM solutions were prepared at various concentra-
tions and loaded (100 μL each) independently into the prepared wells. The mixtures were incubated at 37 °C for 
1 hr and each well was washed again. The solutions of detecting-primary antibodies against BSA (mouse IgG) and 
EpCAM (mouse IgG) were prepared and loaded (100 μL each) into the prepared wells. The mixtures were incu-
bated at 37 °C for 1 hr and each well was washed three times with 250 μL of PBST. HRP-conjugated anti-mouse 
secondary antibodies (Abcam) were added (100 μL each) and incubated at 37 °C for 1 more hour, and the mix-
tures were washed three times with 250 μL PBST. Subsequently, 100 μL of the substrate solution was loaded into 
each well and the reactions were stopped 2 min later by adding 100 μL of 2 N H2SO4 solution into each well.
TSA-based cell immunohistochemistry. Tyramide signal amplification (TSA) kits were purchased from 
Life Technology and all reagents were prepared per the manufacturer’s guidelines. The cell lines, SKBR3 and 
KB, were obtained from the Korean cell line bank (KCLB). The SKBR3 and KB cells were cultured in RPMI1640 
medium with L-glutamine (300 mg/L), 10% fetal bovine serum (FBS, Invitrogen), antibiotics (1,000 units/ml pen-
icillin, 10,000 μg/ml streptomycin, and 25 μg/ml amphotericin B), 25 mM HEPES, and 25 mM NaHCO3 at 37 °C 
under 5% CO2.
For the TSA assays, SKBR3 and KB cells were grown in 12-well microscopy chambers (1 × 105 cells/well), 
washed with PBST, fixed with 4% paraformaldehyde at 4 °C for 20 min, and finally washed again with PBST. The 
fixed cells were permeabilized with 0.1% Triton® X-100 solution at room temperature for 10 min and rinsed with 
PBST. The fixed SKBR3 and KB cells were treated with anti-HER2 rabbit primary antibodies and anti-integrin 
α β γ 3 mouse primary antibodies, respectively, at room temperature for 1 hr and washed with PBST to remove 
unbound or non-specifically bound antibodies. The HRP-conjugated rabbit or mouse secondary antibodies 
were prepared by diluting the stock solution 1:100 in 1% blocking solution, and HRP-GST-ABD was prepared at 
equivalent amounts in the same solution. The primary antibody-treated cells were treated with the solutions of 
HRP-conjugated secondary antibodies or HRP-GST-ABD (100 μL each) at room temperature for 1 hr and rinsed 
again with PBST to remove HRP-conjugates. Tyramide working solution was freshly prepared by diluting the 
tyramide stock solution 1:100 in amplification buffer with 0.0015% H2O2 just before the reactions, and 100 μL 
was added to each sample. The reaction mixtures were incubated at room temperature for 10 min and rinsed with 
PBST. The nuclei of the cells were also stained with 6-diamidino-2-phenylindole (DAPI, Sigma). Fluorescence cell 
images were obtained using an Olympus Fluoview FV1000 confocal microscope (Olympus, UOBC).
Embryonic sample preparation. To analyze a recombinant secondary antibody mimic (HRP-GST-ABD), 
we fixed embryos between stage 40 or 45 using MEMFA (MEM salts and 4% formaldehyde) or Dent’s fixative 
solution (methanol and 20% DMSO). Then, the fixed embryos were either used for immunostaining directly or 
transverse sections were prepared with 50-μm thickness at the forebrain region using a vibratome. All animal 
studies were performed in compliance with the guidelines of the local ethics committee for animal care and use, 
and were approved by the Institutional Animal Care and Use Committee of Ulsan National Institute of Science 
and Technology.
TSA-based immunohistochemistry of sectioned embryonic slices and whole embryos. 
Embryos or sectioned embryonic slices were incubated in blocking solution (5% BSA + 2% DMSO in TBS + 0.1% 
Triton X-100) at room temperature for 30 min to block nonspecific binding. TSA-staining was performed with 
the following primary antibodies: anti-acetylated tubulin (Sigma-Aldrich), anti-phospho-histone H3 (Abcam), 
anti-fibronectin (DSHB), and anti-MHC (DSHB) at a 1:300 or 1:1,000 dilution for 3 hr at room temperature. 
The samples were rinsed with TBST (TBS + 0.1% Triton X-100). Labeling was performed with HRP-conjugated 
secondary antibodies (Sigma-Aldrich) or HRP-GST-ABD at 1:1,000 dilution for 2 hr. For the HRP-GST-ABD, the 
indicated primary antibody was pre-incubated with HRP-GST-ABD in a 1:1 ratio (0.8 ng/μl each) and the tissue 
samples were incubated with the mixture. Tyramide labeling was performed using tyramide Alexa-488 in ampli-
fication buffer with 0.00015% hydrogen peroxide. The mixtures were incubated at room temperature for 2 min 
and the tissue samples were rinsed with TBST. The nuclei were stained with DAPI (Abcam). All sectioned slices 
were run through washes in 100% methanol before clearing in BA:BB (benzyl alcohol/benzyl benzoate, 1:2) and 
mounting on slides for imaging. Images were captured using a confocal microscope (LSM700).
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